BioCentury
ARTICLE | Company News

Altravax, National Institutes of Health infectious news

January 14, 2013 8:00 AM UTC

Altravax received $1.2 million in two equal Advanced Technology Small Business Innovation Research grants from NIH's National Institute of Allergy and Infectious Diseases for research on vaccines to p...